Helen Sabzevari - Jul 17, 2021 Form 4 Insider Report for PRECIGEN, INC. (PGEN)

Role: President and CEO, Director
Signature: /s/ Helen Sabzevari, by Donald P. Lehr, as attorney-in-fact
Stock symbol: PGEN
Transactions as of: Jul 17, 2021
Transactions value $: -$68,047
Form type: 4
Date filed: 7/20/2021, 06:11 PM
Previous filing: Jun 28, 2021
Next filing: Jan 4, 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PGEN	Common Stock	Options Exercise		+25K	+3.55%		730K	Jul 17, 2021	Direct	F1
transaction	PGEN	Common Stock	Sale	-$68K	-12.5K	-1.72%	$5.43	718K	Jul 19, 2021	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PGEN	Restricted Stock Units	Options Exercise	$0	-25K	-100%	$0.00^*	0	Jul 17, 2021	Common Stock	25K		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ('RSU") represents a contingent right to receive one share of Precigen common stock.
F2	This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of RSUs.
F3	The RSUs were granted on March 28, 2018 and have vested in full.